(4R,7R,8S,9S,10Z,13Z,16S)-4,8-bis[[tert-butyl(dimethyl)silyl]oxy]-5,5,7,9,13-pentamethyl-16-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxa-6-thiacyclohexadeca-10,13-dien-2-one;(4R,7R,8S,9S,10Z,13Z,16S)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxa-6-thiacyclohexadeca-10,13-dien-2-one
C64H106N2O8S4Si2 — CID 158547975
Data last refreshed: (MolForge compound catalog, from PubChem)
About (4R,7R,8S,9S,10Z,13Z,16S)-4,8-bis[[tert-butyl(dimethyl)silyl]oxy]-5,5,7,9,13-pentamethyl-16-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxa-6-thiacyclohexadeca-10,13-dien-2-one;(4R,7R,8S,9S,10Z,13Z,16S)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxa-6-thiacyclohexadeca-10,13-dien-2-one
(4R,7R,8S,9S,10Z,13Z,16S)-4,8-bis[[tert-butyl(dimethyl)silyl]oxy]-5,5,7,9,13-pentamethyl-16-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxa-6-thiacyclohexadeca-10,13-dien-2-one;(4R,7R,8S,9S,10Z,13Z,16S)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxa-6-thiacyclohexadeca-10,13-dien-2-one (PubChem CID 158547975) has the molecular formula C64H106N2O8S4Si2 and a molecular weight of 1216.00 g/mol. Its IUPAC name is (4R,7R,8S,9S,10Z,13Z,16S)-4,8-bis[[tert-butyl(dimethyl)silyl]oxy]-5,5,7,9,13-pentamethyl-16-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxa-6-thiacyclohexadeca-10,13-dien-2-one;(4R,7R,8S,9S,10Z,13Z,16S)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxa-6-thiacyclohexadeca-10,13-dien-2-one.
Molecular Properties
| Compound Name | (4R,7R,8S,9S,10Z,13Z,16S)-4,8-bis[[tert-butyl(dimethyl)silyl]oxy]-5,5,7,9,13-pentamethyl-16-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxa-6-thiacyclohexadeca-10,13-dien-2-one;(4R,7R,8S,9S,10Z,13Z,16S)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxa-6-thiacyclohexadeca-10,13-dien-2-one |
|---|---|
| PubChem CID | 158547975 |
| Molecular Formula | C64H106N2O8S4Si2 |
| Molecular Weight | 1216.00 g/mol |
| Exact Mass | 1214.64 |
| IUPAC Name | (4R,7R,8S,9S,10Z,13Z,16S)-4,8-bis[[tert-butyl(dimethyl)silyl]oxy]-5,5,7,9,13-pentamethyl-16-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxa-6-thiacyclohexadeca-10,13-dien-2-one;(4R,7R,8S,9S,10Z,13Z,16S)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxa-6-thiacyclohexadeca-10,13-dien-2-one |
| SMILES | C/C1=C/C[C@@H](/C(C)=C/c2csc(C)n2)OC(=O)C[C@@H](O)C(C)(C)S[C@H](C)[C@@H](O)[C@@H](C)/C=C\C1.C/C1=C/C[C@@H](/C(C)=C/c2csc(C)n2)OC(=O)C[C@@H](O[Si](C)(C)C(C)(C)C)C(C)(C)S[C@H](C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H](C)/C=C\C1 |
| InChI | InChI=1S/C38H67NO4S2Si2.C26H39NO4S2/c1-26-19-18-20-27(2)35(43-47(16,17)37(9,10)11)29(4)45-38(12,13)33(42-46(14,15)36(6,7)8)24-34(40)41-32(22-21-26)28(3)23-31-25-44-30(5)39-31;1-16-9-8-10-17(2)25(30)19(4)33-26(6,7)23(28)14-24(29)31-22(12-11-16)18(3)13-21-15-32-20(5)27-21/h18,20-21,23,25,27,29,32-33,35H,19,22,24H2,1-17H3;8,10-11,13,15,17,19,22-23,25,28,30H,9,12,14H2,1-7H3/b20-18-,26-21-,28-23+;10-8-,16-11-,18-13+/t27-,29+,32-,33+,35-;17-,19+,22-,23+,25-/m00/s1 |
| InChIKey | HPJCMDVVJUAXMY-DYDMOJKPSA-N |
| XLogP | 17.48 |
| TPSA | 137.30 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 14 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 80 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1216.00 |
| LogP ≤ 5 | 17.48 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 14 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158547975 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.